GW&K Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.8M | Sell |
33,431
-1,427
| -4% | -$162K | 0.03% | 278 |
|
|
2025
Q1 | $3.67M | Sell |
34,858
-326
| -0.9% | -$34.3K | 0.03% | 282 |
|
|
2024
Q4 | $3.77M | Sell |
35,184
-2,577
| -7% | -$276K | 0.03% | 290 |
|
|
2024
Q3 | $3.78M | Sell |
37,761
-1,257
| -3% | -$126K | 0.03% | 281 |
|
|
2024
Q2 | $3.29M | Sell |
39,018
-747
| -2% | -$62.9K | 0.03% | 286 |
|
|
2024
Q1 | $2.91M | Sell |
39,765
-15,570
| -28% | -$1.14M | 0.03% | 293 |
|
|
2023
Q4 | $3.95M | Buy |
55,335
+17,905
| +48% | +$1.28M | 0.04% | 276 |
|
|
2023
Q3 | $2.24M | Sell |
37,430
-678
| -2% | -$40.6K | 0.02% | 304 |
|
|
2023
Q2 | $2.75M | Sell |
38,108
-750
| -2% | -$54.1K | 0.03% | 301 |
|
|
2023
Q1 | $2.86M | Buy |
38,858
+8,764
| +29% | +$645K | 0.03% | 292 |
|
|
2022
Q4 | $2.01M | Sell |
30,094
-18,644
| -38% | -$1.25M | 0.02% | 307 |
|
|
2022
Q3 | $2.62M | Sell |
48,738
-5,219
| -10% | -$280K | 0.03% | 290 |
|
|
2022
Q2 | $3M | Sell |
53,957
-1,944
| -3% | -$108K | 0.03% | 278 |
|
|
2022
Q1 | $3.92M | Buy |
55,901
+15,008
| +37% | +$1.05M | 0.04% | 274 |
|
|
2021
Q4 | $3.94M | Buy |
+40,893
| New | +$3.94M | 0.03% | 282 |
|